Eli Lilly



Ebit تغيير تاريخ
AbbVie USD 5.72B 69M 2025-06
Abbott USD 2.07B 105M 2025-06
ALKERMES USD 92.98M 79.19M 2025-06
Amgen USD 2.26B 1.34B 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Baxter International USD 272M 120M 2025-06
Biogen USD 816.6M 233.8M 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 7.02B 3.32B 2025-06
Gilead Sciences USD 2.7B 189M 2025-06
GlaxoSmithKline GBP 2.07B 462M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
J&J USD 6.94B 443M 2025-06
Medtronic USD 1.52B 969M 2025-07
Merck USD 6.36B 149M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Novartis USD 4.86B 286M 2024-12
Novo Nordisk 34.08B 4.71B 2025-06
Perrigo USD 55.6M 91M 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Prestige Brands USD 71.76M 29.14M 2025-06
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 1.51B 1.39B 2025-06
Sanofi EUR 2.22B 2.84B 2024-12
United Therapeutics USD 276.9M 105.9M 2025-06
Zoetis USD 1.02B 106M 2025-06


Eli Lilly - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.